126 related articles for article (PubMed ID: 28841022)
1. Combination Treatment of Citral Potentiates the Efficacy of Hyperthermic Intraperitoneal Chemoperfusion with Pirarubicin for Colorectal Cancer.
Fang Z; Wang Y; Li H; Yu S; Liu Z; Fan Z; Chen X; Wu Y; Pan X; Li X; Wang C
Mol Pharm; 2017 Oct; 14(10):3588-3597. PubMed ID: 28841022
[TBL] [Abstract][Full Text] [Related]
2. Antiproliferative and apoptosis inducing effects of citral via p53 and ROS-induced mitochondrial-mediated apoptosis in human colorectal HCT116 and HT29 cell lines.
Sheikh BY; Sarker MMR; Kamarudin MNA; Mohan G
Biomed Pharmacother; 2017 Dec; 96():834-846. PubMed ID: 29078261
[TBL] [Abstract][Full Text] [Related]
3. Hyperthermic intraperitoneal chemotherapy using a combination of mitomycin C,5-fluorouracil, and oxaliplatin in patients at high risk of colorectal peritoneal metastasis: A Phase I clinical study.
Shimizu T; Sonoda H; Murata S; Takebayashi K; Ohta H; Miyake T; Mekata E; Shiomi H; Naka S; Tani T
Eur J Surg Oncol; 2014 May; 40(5):521-528. PubMed ID: 24388411
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant chemotherapy with bevacizumab may improve outcome after cytoreduction and hyperthermic intraperitoneal chemoperfusion (HIPEC) for colorectal carcinomatosis.
Ceelen W; Van Nieuwenhove Y; Putte DV; Pattyn P
Ann Surg Oncol; 2014 Sep; 21(9):3023-8. PubMed ID: 24756812
[TBL] [Abstract][Full Text] [Related]
5. Hyperthermic intraperitoneal chemotherapy + early postoperative intraperitoneal chemotherapy versus hyperthermic intraperitoneal chemotherapy alone: assessment of survival outcomes for colorectal and high-grade appendiceal peritoneal carcinomatosis.
Lam JY; McConnell YJ; Rivard JD; Temple WJ; Mack LA
Am J Surg; 2015 Sep; 210(3):424-30. PubMed ID: 26051744
[TBL] [Abstract][Full Text] [Related]
6. 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer.
Verwaal VJ; Bruin S; Boot H; van Slooten G; van Tinteren H
Ann Surg Oncol; 2008 Sep; 15(9):2426-32. PubMed ID: 18521686
[TBL] [Abstract][Full Text] [Related]
7. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with oxaliplatin for peritoneal carcinomatosis arising from colorectal cancer.
Gervais MK; Dubé P; McConnell Y; Drolet P; Mitchell A; Sideris L
J Surg Oncol; 2013 Dec; 108(7):438-43. PubMed ID: 24018983
[TBL] [Abstract][Full Text] [Related]
8. Applications of hyperthermic intraperitoneal chemotherapy for metastatic colorectal cancer.
Hornung M; Werner JM; Schlitt HJ
Expert Rev Anticancer Ther; 2017 Sep; 17(9):841-850. PubMed ID: 28715968
[TBL] [Abstract][Full Text] [Related]
9. Consensus guidelines from The American Society of Peritoneal Surface Malignancies on standardizing the delivery of hyperthermic intraperitoneal chemotherapy (HIPEC) in colorectal cancer patients in the United States.
Turaga K; Levine E; Barone R; Sticca R; Petrelli N; Lambert L; Nash G; Morse M; Adbel-Misih R; Alexander HR; Attiyeh F; Bartlett D; Bastidas A; Blazer T; Chu Q; Chung K; Dominguez-Parra L; Espat NJ; Foster J; Fournier K; Garcia R; Goodman M; Hanna N; Harrison L; Hoefer R; Holtzman M; Kane J; Labow D; Li B; Lowy A; Mansfield P; Ong E; Pameijer C; Pingpank J; Quinones M; Royal R; Salti G; Sardi A; Shen P; Skitzki J; Spellman J; Stewart J; Esquivel J
Ann Surg Oncol; 2014 May; 21(5):1501-5. PubMed ID: 23793364
[TBL] [Abstract][Full Text] [Related]
10. Styrene maleic acid copolymer-pirarubicin induces tumor-selective oxidative stress and decreases tumor hypoxia as possible treatment of colorectal cancer liver metastases.
Daruwalla J; Greish K; Malcontenti-Wilson C; Muralidharan V; Maeda H; Christophi C
Surgery; 2015 Jul; 158(1):236-47. PubMed ID: 25999256
[TBL] [Abstract][Full Text] [Related]
11. Histological response of peritoneal carcinomatosis after hyperthermic intraperitoneal chemoperfusion (HIPEC) in experimental investigations.
Pelz JO; Doerfer J; Dimmler A; Hohenberger W; Meyer T
BMC Cancer; 2006 Jun; 6():162. PubMed ID: 16792796
[TBL] [Abstract][Full Text] [Related]
12. Near-infrared light triggered drug delivery system for higher efficacy of combined chemo-photothermal treatment.
Chen Y; Li H; Deng Y; Sun H; Ke X; Ci T
Acta Biomater; 2017 Mar; 51():374-392. PubMed ID: 28088668
[TBL] [Abstract][Full Text] [Related]
13. Cytoreduction and hyperthermic intraperitoneal chemotherapy (CS/HIPEC) in colorectal cancer: Evidence-based review of patient selection and treatment algorithms.
Maciver AH; Lee N; Skitzki JJ; Boland PM; Francescutti V
Eur J Surg Oncol; 2017 Jun; 43(6):1028-1039. PubMed ID: 28029523
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the effect of SMA-pirarubicin micelles on colorectal cancer liver metastases and of hyperbaric oxygen in CBA mice.
Daruwalla J; Greish K; Nikfarjam M; Millar I; Malcontenti-Wilson C; Iyer AK; Christophi C
J Drug Target; 2007; 15(7-8):487-95. PubMed ID: 17671895
[TBL] [Abstract][Full Text] [Related]
15. Peritoneal metastases from colorectal cancer: patient selection for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Riss S; Mohamed F; Dayal S; Cecil T; Stift A; Bachleitner-Hofmann T; Moran B
Eur J Surg Oncol; 2013 Sep; 39(9):931-7. PubMed ID: 23810280
[TBL] [Abstract][Full Text] [Related]
16. Safety of intraperitoneal Mitomycin C versus intraperitoneal oxaliplatin in patients with peritoneal carcinomatosis of colorectal cancer undergoing cytoreductive surgery and HIPEC.
van Eden WJ; Kok NFM; Woensdregt K; Huitema ADR; Boot H; Aalbers AGJ
Eur J Surg Oncol; 2018 Feb; 44(2):220-227. PubMed ID: 29258720
[TBL] [Abstract][Full Text] [Related]
17. Effect of citral on the cytotoxicity of doxorubicin in human B-lymphoma cells.
Dangkong D; Limpanasithikul W
Pharm Biol; 2015 Feb; 53(2):262-8. PubMed ID: 25243873
[TBL] [Abstract][Full Text] [Related]
18. HIPECT4: multicentre, randomized clinical trial to evaluate safety and efficacy of Hyperthermic intra-peritoneal chemotherapy (HIPEC) with Mitomycin C used during surgery for treatment of locally advanced colorectal carcinoma.
Arjona-Sánchez A; Barrios P; Boldo-Roda E; Camps B; Carrasco-Campos J; Concepción Martín V; García-Fadrique A; Gutiérrez-Calvo A; Morales R; Ortega-Pérez G; Pérez-Viejo E; Prada-Villaverde A; Torres-Melero J; Vicente E; Villarejo-Campos P; Sánchez-Hidalgo JM; Casado-Adam A; García-Martin R; Medina M; Caro T; Villar C; Aranda E; Cano-Osuna MT; Díaz-López C; Torres-Tordera E; Briceño-Delgado FJ; Rufián-Peña S
BMC Cancer; 2018 Feb; 18(1):183. PubMed ID: 29439668
[TBL] [Abstract][Full Text] [Related]
19. Predicting the survival of patients with peritoneal carcinomatosis of colorectal origin treated by aggressive cytoreduction and hyperthermic intraperitoneal chemotherapy.
Verwaal VJ; van Tinteren H; van Ruth S; Zoetmulder FA
Br J Surg; 2004 Jun; 91(6):739-46. PubMed ID: 15164445
[TBL] [Abstract][Full Text] [Related]
20. Gene expression changes induced by HIPEC in a murine model of gastric cancer.
Graziosi L; Mencarelli A; Renga B; Santorelli C; Cantarella F; Bugiantella W; Cavazzoni E; Donini A; Fiorucci S
In Vivo; 2012; 26(1):39-45. PubMed ID: 22210714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
